InVivo Therapeutics announced the appointment of Mark Perrin as CEO, effective Jan. 6.
Healthcare PR giant Dan Edelman dies; Pfizer says 'no comment' on breakup speculation; Publicis Healthcare snags a new SVP; Lippincott gives nurses a new drug diagnosis tool.
A third-party review says FDA employees need more support; Shire launches rare disease research; and Bayer drops Schiff bid
Merck slims down, Novo goes wide
MM&M's 26th annual Career & Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.